Chart(x) E.H.R. 3.0

Measure 6 Medication Allergy List

6 of 15 Core

Stage 1

 
Medication Allergy List
 
Objective
Maintain active medication allergy list.
Measure
More than 80 percent of all unique patients seen by the EP have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data.
Exclusion
No exclusion.
 
 

Definition of Terms

Active Medication Allergy List - A list of medications to which a given patient has known allergies.
 
Allergy - An exaggerated immune response or reaction to substances that are generally not harmful.
 
Unique Patient - If a patient is seen by an EP more than once during the EHR reporting period, then for purposes of measurement that patient is only counted once in the denominator for the measure. All the measures relying on the term " Unique Patient" relate to what is contained in the patient's medical record. Not all of this information will need to be update or even be needed by the provider at every patient encounter. This is especially true for patients whose encounter frequency is such that they would see the same provider multiple times in the same EHR reporting period.
 

Attestation Requirements

 
NUMERATOR / DENOMINATOR
 
  • DENOMINATOR: Number of unique patients seen by the EP during the EHR reporting period.
  • NUMERATOR: Number of unique patients in the denominator who have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data in their medication allergy list.
 
The resulting percentage must be more than 80 percent in order for an EP to meet this measure.
 

Additional Information

 
  • For patients with no active medication allergies, an entry must still be made to the active medication allergy list indicating that there are no active medication allergies.
An EP is not required to update this list at every contact with the patient. The measure ensures that the EP has not ignored having a medication allergy list for patients seen during the EHR reporting period and that at least one piece of information on medication allergies is presented to the EP. The EP can then use their judgement in deciding what further probing or updating may be required given the clinical circumstances at hand.

Built with help of DrExplain

All rights reserved Connect(x) HealthWare LLC 2011